SLE Pathogenesis
•Immune activation
•Target organ injury Epidemiology
Prevalence: 17-48/100,000 worldwide but as high as 207/100,000 in an AfroCaribbean population in England Female:Male ratio is approximately 9:1 post-puberty and pre-menopausal Ethnic Variance: More common in Black (3x), Hispanic (2-3x) and Asian 2x) populations 1. Malar Rash: fixed erythema, flat or raised, over the malar eminences, sparing the nasolabial folds 2.
Discoid Rash: Erythematous raised patches with adherent keratotic scaling and follicular plugging: scarring may occur 3.
Photosensitivity: Reaction to sunlight, resulting in the development of or increase in skin rash 4.
Oral Ulcers: Oral or nasopharyngial ulceration, usually painless 5.
Arthritis: Nonerosive arthritis involving two or more peripheral joints 6.
Serositis: Pleuritis or pericarditis 7.
Renal Disorder: proteinuria greater than .5 gm/day and/or cellular casts 8.
Neurologic Disorder: Seizures and/or psychosis in the absence of drugs or metabolic disturbances which are known to cause such effects 9.
Hematologic Disorder: Hemolytic anemia , leukopenia (< 4000), lymphopenia (<1500) or thrombocytopenia (<100,000) 
